1. Information about Nitrosamine Impurities in Medications,2021
2. ICH. ICH Harmonised Guideline. Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk M7(R1). 2017. Current Step 4 version dated 31. 2017. Available at: https://database.ich.org/sites/default/files/M7_R1_Guideline.pdf. Accessed February 02, 2023.
3. DNA damage and mutation. Types of DNA damage;Chakarov;Biodiscovery,2014
4. Metabolic activation and DNA interactions of carcinogenic n-nitrosamines to which humans are commonly exposed;Li;Int J Mol Sci,2022
5. A genome-wide portrait of pervasive drug contaminants;Ogbede;Sci Rep,2021